We are on a mission to transform the diagnostics of infectious diseases by identifying pathogens involved, through their gas biomarkers.

Discover our solution

  1. Technology

    Enhancing Gold Standard pathogen cultures, AI and gas biomarkers detection

  2. Value

    Simplifying the process of pathogen detection and identification

    Lowering the cost of care

    Reduction of antibiotic consumption addressing the challenge of Antimicrobial Resistance (AMR)

  3. Team

    2nd venture after successful exit

    Interdisciplinary team comprising scientists, engineers, and clinicians

About Zynnon

We serve the Clinical Diagnostics and Industrial Microbiology markets

Enhancing Gold Standard pathogen cultures through gas biomarkers

Discover Zynnon

We innovate for smarter health.

News

26. 09. 24

BIOASTER collaborates with ZYNNON to advance VOC-based detection and identification
12. 09. 24

Zynnon welcomes Dr. Mark Miller as an Advisor
20. 12. 23

Transforming the diagnostic of respiratory infections: Zynnon hits a key milestone with its breakthrough solution
13. 09. 23

Revolutionizing Respiratory Infection Detection: Zynnon’s Breakthrough Clinical Study Yields Promising Results
27. 06. 22

Zynnon raises CHF800,000 in seed funding to detect the risk of respiratory infection transmission

Partners